[Analysis of distribution and drug resistance of pathogens of burn patients during 9 years]
- PMID: 29609277
- DOI: 10.3760/cma.j.issn.1009-2587.2018.03.008
[Analysis of distribution and drug resistance of pathogens of burn patients during 9 years]
Abstract
Objective: To investigate distribution and drug resistance of pathogens of burn patients. Methods: A total of 3 357 strains were cultured and isolated from 25 286 specimens of wounds excretion, deep venous catheters, venous blood, stool, mid-stream urine, sputum, puncture fluid, and throat swab of 11 510 burn patients hospitalized in our burn wards from January 2007 to December 2015. After being identified by API bacteria identification panels and automatically bacteria identification equipment, drug-resistances of Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae to 28 common antibiotics were tested by drug sensitivity test with K-B paper disk diffusion method. The WHONET 5.6 software was used to analyze constituent ratio of gram-negative bacteria and gram-positive bacteria in each year, distribution of pathogens in each year, and drug resistance of the above-mentioned 4 pathogens in 9 years to 28 common antibiotics. Data were analyzed by the linear model curve fitting. Results: (1) From 2007 to 2015, constituent ratios of gram-negative bacteria were respectively 41.22% (101/245), 41.88% (165/394), 45.92% (169/368), 42.54% (208/489), 52.35% (267/510), 56.89% (194/341), 58.99% (210/356), 56.95% (172/302), and 50.28% (177/352), with significantly increasing trend (R(2)=0.625, P<0.05); constituent ratios of gram-positive bacteria were respectively 58.78% (144/245), 58.12% (229/394), 54.08% (199/368), 57.46% (281/489), 47.65% (243/510), 43.11% (147/341), 41.01% (146/356), 43.05% (130/302), 49.72% (175/352), with significantly decreasing trend (R(2)=0.625, P<0.05). In 9 years, constituent ratio of Staphylococcus aureus ranked the first in all bacteria, and constituent ratios of Pseudomonas aeruginosa and Klebsiella pneumoniae were with significantly increasing trend (R(2)=0.811, 0.778, P<0.01). (2) In 9 years, drug-resistant rates of Staphylococcus aureus to gentamycin and rifampicin were with significantly decreasing trend (R(2)=0.727, 0.766, P<0.01); drug-resistant rates of Staphylococcus aureus to phosphonomycin were always in lower levels of 4.6% to 19.5%. In 9 years, drug-resistant rates of Pseudomonas aeruginosa to ceftazidime and ciprofloxacin had no significant change in trend (R(2)=0.023, <0.001, P>0.05), while drug-resistant rates of Pseudomonas aeruginosa to other 10 common antibiotics were with significantly increasing trend (R(2)=0.764, 0.793, 0.785, 0.768, 0.752, 0.749, 0.789, 0.786, 0.706, 0.629, P<0.01). In 9 years, drug-resistant rate of Acinetobacter baumannii to ampicillin/sulbactam was with significantly decreasing trend (R(2)=0.652, P<0.01), and drug-resistant rate of Acinetobacter baumannii to amikacin was with significantly increasing trend ( R(2)=0.531, P<0.05). In 9 years, drug-resistant rates of Klebsiella pneumoniae to piperacillin, ampicillin/sulbactam, cefuroxime, ceftazidime, cefotaxime, cefepime, imipenem, meropenem, amikacin, and gentamicin were with obviously increasing trend (R(2)=0.481, 0.672, 0.694, 0.532, 0.810, 0.641, 0.809, 0.709, 0.579, 0.810, P<0.05 or P<0.01). Conclusions: Constituent ratios of gram-positive bacteria of Pseudomonas aeruginosa and Klebsiella pneumoniae of burn patients hospitalized in our burn wards from 2007 to 2015 were significantly increased, while constituent ratios of Staphylococcus aureus of those children always ranked the first. Drug-resistence of bacteria of those children in our burn wards was serious. Drug-resistant rate of Staphylococcus aureus only to phosphonomycin was always in lower level. Drug-resistant rates of Pseudomonas aeruginosa to 10 common antibiotics except ceftazidime and ciprofloxacin were significantly increased. Drug-resistant rate of Acinetobacter baumannii only to ampicillin/sulbactam was significantly decreased. Drug-resistant rates of Klebsiella pneumoniae to most common antibiotics were significantly increased.
目的: 了解烧伤患者病原菌分布特点及耐药情况。 方法: 收集2007年1月—2015年12月笔者单位收治的11 510例住院烧伤患者的创面分泌物、深静脉导管、静脉血、大便、中段尿液、痰液、穿刺液、咽拭子标本25 286份,行细菌培养,共分离出3 357株菌株。采用API细菌鉴定板条和全自动细菌鉴定仪进行菌种鉴定,K-B纸片扩散法进行药物敏感试验,检测金黄色葡萄球菌、铜绿假单胞菌、鲍氏不动杆菌及肺炎克雷伯菌对28种常用抗菌药物的耐药情况。采用WHONET 5.6软件统计各年度革兰阴性菌和革兰阳性菌构成比、各年度检出病原菌分布情况及9年间检出的金黄色葡萄球菌、铜绿假单胞菌、肺炎克雷伯菌及鲍氏不动杆菌对28种常用抗菌药物的耐药情况。对数据行线性模型曲线拟合。 结果: (1)2007—2015年,革兰阴性菌构成比分别为41.22%(101/245)、41.88%(165/394)、45.92%(169/368)、42.54%(208/489)、52.35%(267/510)、56.89%(194/341)、58.99%(210/356)、56.95%(172/302)、50.28%(177/352),呈明显上升趋势(R(2)=0.625,P<0.05);革兰阳性菌构成比分别为58.78%(144/245)、58.12%(229/394)、54.08%(199/368)、57.46%(281/489)、47.65%(243/510)、43.11%(147/341)、41.01%(146/356)、43.05%(130/302)、49.72%(175/352),呈明显下降趋势(R(2)=0.625,P<0.05)。9年间,金黄色葡萄球菌构成比一直居于首位,铜绿假单胞菌和肺炎克雷伯菌构成比呈明显上升趋势(R(2)=0.811、0.778,P<0.01)。(2)9年间,金黄色葡萄球菌对庆大霉素和利福平的耐药率呈明显下降趋势(R(2)=0.727、0.766,P<0.01),对磷霉素的耐药率始终处于较低水平(4.6%~19.5%);铜绿假单胞菌对头孢他啶、环丙沙星的耐药率无明显变化趋势(R(2)=0.023、<0.001,P>0.05),而对其他10种常用抗菌药物的耐药率呈明显上升趋势(R(2)=0.764、0.793、0.785、0.768、0.752、0.749、0.789、0.786、0.706、0.629,P<0.01);鲍氏不动杆菌对氨苄西林/舒巴坦的耐药率呈明显下降趋势(R(2)=0.652,P<0.01),对阿米卡星的耐药率呈明显上升趋势(R(2)=0.531,P<0.05);肺炎克雷伯菌对哌拉西林、氨苄西林/舒巴坦、头孢呋辛、头孢他啶、头孢噻肟、头孢吡肟、亚胺培南、美罗培南、阿米卡星、庆大霉素的耐药率呈明显上升趋势(R(2)=0.481、0.672、0.694、0.532、0.810、0.641、0.809、0.709、0.579、0.810,P<0.05或P<0.01)。 结论: 笔者单位2007—2015年收治住院烧伤患者检出铜绿假单胞菌和肺炎克雷伯菌等革兰阴性菌构成比显著上升,但金黄色葡萄球菌构成比仍居于首位;细菌耐药情况严重,金黄色葡萄球菌仅对磷霉素耐药率一直处于较低水平,铜绿假单胞菌对除头孢他啶和环丙沙星外的10种常用抗菌药物的耐药率显著上升,鲍氏不动杆菌仅对氨苄西林/舒巴坦的耐药率显著下降,肺炎克雷伯菌对大多数常用抗菌药物的耐药率显著上升。.
Keywords: Bacteria; Burns; Drug resistance; Infection.
Similar articles
-
[Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].Zhonghua Shao Shang Za Zhi. 2018 Nov 20;34(11):802-808. doi: 10.3760/cma.j.issn.1009-2587.2018.11.016. Zhonghua Shao Shang Za Zhi. 2018. PMID: 30481922 Chinese.
-
[Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].Zhonghua Shao Shang Za Zhi. 2016 Sep 20;32(9):529-35. doi: 10.3760/cma.j.issn.1009-2587.2016.09.004. Zhonghua Shao Shang Za Zhi. 2016. PMID: 27647068 Chinese.
-
[Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].Zhonghua Shao Shang Za Zhi. 2014 Feb;30(1):9-14. Zhonghua Shao Shang Za Zhi. 2014. PMID: 24684983 Chinese.
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
-
[Guidelines for treatment of pneumonia in intensive care units].Infez Med. 2005;Suppl:7-17. Infez Med. 2005. PMID: 16801748 Review. Italian.
Cited by
-
Application of Phagotherapy in the Treatment of Burn Patients (Review).Sovrem Tekhnologii Med. 2021;12(3):95-103. doi: 10.17691/stm2020.12.3.12. Epub 2020 Jun 28. Sovrem Tekhnologii Med. 2021. PMID: 34795985 Free PMC article. Review.
-
Analysis of Bactericidal Effect of Three Medical Ozonation Dosage Forms on Multidrug-Resistant Bacteria from Burn Patients.Infect Drug Resist. 2022 Apr 6;15:1637-1643. doi: 10.2147/IDR.S353277. eCollection 2022. Infect Drug Resist. 2022. PMID: 35418764 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical